Back
Profire Energy 10K Form
Buy
60
PFIE
Profire Energy
Last Price:
1.63
Seasonality Move:
3.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | PFIE/Profire Energy Quarterly |
2023-11-08 | 10Q | PFIE/Profire Energy Quarterly |
2023-08-09 | 10Q | PFIE/Profire Energy Quarterly |
2023-05-09 | 10Q | PFIE/Profire Energy Quarterly |
2022-11-02 | 10Q | PFIE/Profire Energy Quarterly |
2022-08-04 | 10Q | PFIE/Profire Energy Quarterly |
Receive PFIE News And Ratings
See the #1 stock for the next 7 days that we like better than PFIE
PFIE Financial Statistics
Sales & Book Value
Annual Sales: | $58.21M |
---|---|
Cash Flow: | $2.18M |
Price / Cash Flow: | 23.63 |
Annual Sales: | $1.28 |
Price / Book: | 1.26 |
Profitability
EPS (TTM): | 0.18000 |
---|---|
Net Income (TTM): | $8.83M |
Gross Margin: | $30.53M |
Return on Equity: | 15.58% |
Return on Assets: | 13.72% |
Profire Energy Earnings Forecast
Key Profire Energy Financial Ratios
- The Gross Profit Margin over the past 19 years for PFIE is 52.45%.
- The Selling, General & Administrative Expenses for PFIE have been equal to 29.52% of Gross Profit Margin.
- The Research & Development expenses have been 1.58% of Revenue.
- The Interest Expense is 0.09% of Operating Income.
- The Net Earning history of PFIE is 18.51% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 11 years.
Profire Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Energy Equipment & Services |
Sector: | Energy |
Current Symbol: | PFIE |
CUSIP: | 74316X |
Website: | profireenergy.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.93 |
Quick Ratio: | 4.06 |
Price-to-Earnings
Trailing P/E Ratio: | 7.41 |
---|---|
Forward P/E Ratio: | 9.88 |
PFIE Technical Analysis vs Fundamental Analysis
Buy
60
Profire Energy (PFIE)
is a Buy
Is Profire Energy a Buy or a Sell?
-
Profire Energy stock is rated a Buy
The current Profire Energy [PFIE] share price is $1.63. The Score for PFIE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.